Meeting Abstract
Genitourinary (Non-Prostate) Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Emily Lemke, DNP, AGPCNP-BC, AOCNP®
Medical College of Wisconsin Cancer Center
J Adv Pract Oncol 2021;12(6):615-619 |
https://doi.org/10.6004/jadpro.2021.12.6.8 |
© 2021 Harborside™
ABSTRACT
Following coverage from The ASCO Post, Emily Lemke, DNP, AGPCNP-BC, AOCNP®, of Medical College of Wisconsin Cancer Center, comments on an adjuvant trial of a checkpoint inhibitor for clear cell renal cell carcinoma (RCC), real-world data comparing first-line platinum regimens for patients with metastatic urothelial carcinoma, and combination regimens for RCC.
For access to the full length article, please
sign in.
